News | August 07, 2021
Bafna Pharma posts Q1FY 21-22 net at Rs. 2.08 Cr
This robust growth has come despite the raging pandemic for most part of the quarter
This robust growth has come despite the raging pandemic for most part of the quarter
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
The data should be submitted by August 12th 2021
Arrow is the marketing partner in US
Arch Pharma Labs has filed the application
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The govt has rolled out three schemes for promoting the manufacture of API
Takeda Will Focus its Efforts on Dengue, Zika and Pandemic vaccines
The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation
The company is confident of commencing production at both Mahad and Chiplun units soon
Subscribe To Our Newsletter & Stay Updated
